Citation Impact
Citing Papers
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Intensive versus Conventional Glucose Control in Critically Ill Patients
2009 Standout
Intravascular Ultrasound Findings in Patients With Very Late Stent Thrombosis After Either Drug-Eluting or Bare-Metal Stent Implantation
2010
Monitoring of Lipids, Enzymes, and Creatine Kinase in Patients on Lipid-Lowering Drug Therapy
2013
Aortic valve replacement in patients with mild or moderate aortic stenosis and coronary bypass surgery
2005
ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2007
Acute Coronary Care in the Elderly, Part I
2007
Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: executive summary--a Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association (EHRA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
2010
Management of Antithrombotic Therapy in Atrial Fibrillation Patients Presenting with Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention/ Stenting
2009
Physical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine
1995 Standout
Outcomes of patients with acute coronary syndromes and prior percutaneous coronary intervention: a pooled analysis of three randomized clinical trials
2004
Primary Prevention of Coronary Heart Disease in Women through Diet and Lifestyle
2000 Standout
Age and sex differences, and changing trends, in the use of evidence-based therapies in acute coronary syndromes: perspectives from a multinational registry
2010
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis
2013
Antibiotic Treatment ofChlamydia pneumoniaeafter Acute Coronary Syndrome
2005 Standout
Rivaroxaban in Patients with a Recent Acute Coronary Syndrome
2011 Standout
Adherence With Statin Therapy in Elderly Patients With and Without Acute Coronary Syndromes
2002
International Physical Activity Questionnaire: 12-Country Reliability and Validity
2003 Standout
Temporal changes in the management and outcome of Canadian diabetic patients hospitalized for non–ST-elevation acute coronary syndromes
2011
Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction
2004
Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trial
2009
Waiting times, revascularization modality, and outcomes after acute myocardial infarction at hospitals with and without on-site revascularization facilities in Canada
2003
C-Reactive Protein Levels and Outcomes after Statin Therapy
2005 Standout
Diet, Lifestyle, and the Risk of Type 2 Diabetes Mellitus in Women
2001 Standout
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
2009 Standout
Prognostic implications of glucose-lowering treatment in patients with acute myocardial infarction and diabetes: experiences from an extended follow-up of the Diabetes Mellitus Insulin–Glucose Infusion in Acute Myocardial Infarction (DIGAMI) 2 Study
2011
Clinical Outcomes and Stent Thrombosis Following Off-Label Use of Drug-Eluting Stents
2007
Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): a multicentre, double-blind, randomised controlled trial
2008
A Prospective Natural-History Study of Coronary Atherosclerosis
2011 Standout
Three-year follow-up of the ARTS-II# – sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease
2008
2012 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline and Replacing the 2011 Focused Update)
2012
B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
2008 Standout
Fractional Flow Reserve versus Angiography for Guiding Percutaneous Coronary Intervention
2009 Standout
Age, clinical presentation, and outcome of acute coronary syndromes in the Euroheart acute coronary syndrome survey
2006
Previous Coronary Stent Implantation and Cardiac Events in Patients Undergoing Noncardiac Surgery
2010
International differences in in-hospital revascularization and outcomes following acute myocardial infarction A multilevel analysis of patients in ASSENT-2
2003
Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization
2004
Survival of Elderly Patients Undergoing Percutaneous Coronary Intervention for Acute Myocardial Infarction Complicated by Cardiogenic Shock
2009
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
2010 Standout
New natural history of interferon‐β–treated relapsing multiple sclerosis
2007
Management of Perioperative Myocardial Infarction in Noncardiac Surgical Patients
2006
Women with acute coronary syndrome are less invasively examined and subsequently less treated than men
2009
Long-Term Outcomes by Clopidogrel Duration and Stent Type in a Diabetic Population With De Novo Coronary Artery Lesions
2008
Sex, age, and clinical presentation of acute coronary syndromes
2004
Comparison of Treatment and Outcome of Acute Coronary Syndrome in Patients With Versus Patients Without Diabetes Mellitus
2009
Comparison of Baseline Characteristics, Management and Outcome of Patients With Non–ST-Segment Elevation Acute Coronary Syndrome in Versus Not in Clinical Trials
2010
Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication
2005 Standout
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 Standout
Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial
2010
Impact of age on management and outcome of acute coronary syndrome: Observations from the global registry of acute coronary events (GRACE)
2005
The Year in Non–ST-Segment Elevation Acute Coronary Syndrome
2010
Effects of Early Treatment With Statins on Short-term Clinical Outcomes in Acute Coronary Syndromes
2006
Achieving rapid reperfusion with primary percutaneous coronary intervention remains a challenge: Insights from American Heart Association's Get With the Guidelines program
2008
Guidelines for Percutaneous Coronary Interventions
2005
Sex-Based Analysis of Outcome in Patients With Acute Myocardial Infarction Treated Predominantly With Percutaneous Coronary Intervention
2002
Time to Treatment in Primary Percutaneous Coronary Intervention
2007
Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease
2009 Standout
Myocardial Reperfusion Injury
2007 Standout
New concepts in the design of drug-eluting coronary stents
2013
Progress and challenges in translating the biology of atherosclerosis
2011 StandoutNature
Sex-related differences in the presentation, treatment and outcomes among patients with acute coronary syndromes: the Global Registry of Acute Coronary Events
2008
Apixaban, an Oral, Direct, Selective Factor Xa Inhibitor, in Combination With Antiplatelet Therapy After Acute Coronary Syndrome
2009
Inflammation, Atherosclerosis, and Coronary Artery Disease
2005 Standout
Survival after aortic valve replacement forsevere aortic stenosis with low transvalvular gradients and severe left ventricular dysfunction
2002
Routine invasive strategy within 24 hours of thrombolysis versus ischaemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): a randomised controlled trial
2004
2009 ACCF/AHA Focused Update on Perioperative Beta Blockade Incorporated Into the ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery
2009
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Drug-Eluting versus Bare-Metal Stents in Large Coronary Arteries
2010
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)
2011 Standout
Similar outcome with an invasive strategy in men and women with non-ST-elevation acute coronary syndromes
2011
Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes
2004 Standout
The Global Registry of Acute Coronary Events, 1999 to 2009–GRACE
2010
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Intensive Insulin Therapy in the Medical ICU
2006 Standout
Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease
2005 Standout
Cardiovascular diseases in women: a statement from the policy conference of the European Society of Cardiology
2006
Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes
2007 Standout
Adherence to Medication
2005 Standout
2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/ Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline)
2011
Determinants and Prognostic Impact of Heart Failure Complicating Acute Coronary Syndromes
2004
Troponin T Percentiles from a Random Population Sample, Emergency Room Patients and Patients with Myocardial Infarction
2012
Targeting stents with local delivery of paclitaxel-loaded magnetic nanoparticles using uniform fields
2010
Atorvastatin Pretreatment Improves Outcomes in Patients With Acute Coronary Syndromes Undergoing Early Percutaneous Coronary Intervention
2007
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes: Executive Summary
2014
Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol
2019 Standout
Oral Rivaroxaban for Symptomatic Venous Thromboembolism
2010 Standout
2009 ACCF/AHA Focused Update on Perioperative Beta Blockade Incorporated Into the ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery
2009
Early Intensive vs a Delayed Conservative Simvastatin Strategy in Patients With Acute Coronary Syndromes
2004
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
2018 Standout
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
2012 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline and Replacing the 2011 Focused Update)
2012
Comparison of Intensive and Moderate Lipid Lowering With Statins After Acute Coronary Symptoms
2004
Association Between the Use of Fondaparinux vs Low-Molecular-Weight Heparin and Clinical Outcomes in Patients With Non–ST-Segment Elevation Myocardial Infarction
2015
Exercise Capacity and Mortality among Men Referred for Exercise Testing
2002 Standout
Renal failure and acute myocardial infarction: Clinical characteristics in patients with advanced chronic kidney disease, on dialysis, and without chronic kidney disease. A collaborative project of the United States Renal Data System/National Institutes of Health and the National Registry of Myocardial Infarction
2012
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline)
2011
ACSM Position Stand: The Recommended Quantity and Quality of Exercise for Developing and Maintaining Cardiorespiratory and Muscular Fitness, and Flexibility in Healthy Adults
1998 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Randomized, Controlled Trial of Coronary Artery Bypass Surgery Versus Percutaneous Coronary Intervention in Patients With Multivessel Coronary Artery Disease
2008
Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines
2004 Standout
Statin Therapy in Acute Coronary Syndromes
2002
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2011
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Part 14: Pediatric Advanced Life Support
2010 Standout
Hypoxia-inducible factor 1 is required for remote ischemic preconditioning of the heart
2013 StandoutNobel
Basal Insulin and Cardiovascular and Other Outcomes in Dysglycemia
2012 Standout
Treatment Disparities in Acute Coronary Syndromes, Heart Failure, and Kidney Disease
2011
Weekend versus Weekday Admission and Mortality from Myocardial Infarction
2007 Standout
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins
2005 Standout
Hypoxia-inducible factor 1 transcriptional activity in endothelial cells is required for acute phase cardioprotection induced by ischemic preconditioning
2012 StandoutNobel
Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity
2005
2012 ACCF/AHA Focused Update Incorporated Into the ACCF/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2013
Randomized Comparison of Percutaneous Transluminal Coronary Angioplasty and Medical Therapy in Stable Survivors of Acute Myocardial Infarction With Single Vessel Disease
2003
Works of Ulf Stenestrand being referenced
Outcome of ST-elevation myocardial infarction treated with thrombolysis in the unselected population is vastly different from samples of eligible patients in a large-scale clinical trial
2004
Gender differences in management and outcome in non-ST-elevation acute coronary syndrome
2006
Long-Term Safety and Efficacy of Drug-Eluting versus Bare-Metal Stents in Sweden
2009
Relation between renal function, presentation, use of therapies and in‐hospital complications in acute coronary syndrome: data from the SWEDEHEART register
2009
Improved but still high short- and long-term mortality rates after myocardial infarction in patients with diabetes mellitus: a time-trend report from the Swedish Register of Information and Knowledge about Swedish Heart Intensive Care Admission
2007
Cockcroft-Gault is better than the Modification of Diet in Renal Disease study formula at predicting outcome after a myocardial infarction: Data from the Swedish Web-system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies (SWEDEHEART)
2010
Cardiovascular and Cancer Mortality in Very Elderly Post-Myocardial Infarction Patients Receiving Statin Treatment
2010
Long-Term Outcomes with Drug-Eluting Stents versus Bare-Metal Stents in Sweden
2007
Long-term Outcome of Primary Percutaneous Coronary Intervention vs Prehospital and In-Hospital Thrombolysis for Patients With ST-Elevation Myocardial Infarction
2006
Training effects of long versus short bouts of exercise in healthy subjects
1990
The long-term cost-effectiveness of clopidogrel plus aspirin in patients undergoing percutaneous coronary intervention in Sweden
2005
The Swedish Web-system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies (SWEDEHEART)
2010
Early Statin Treatment Following Acute Myocardial Infarction and 1-Year Survival
2001
Fibrinolytic Therapy in Patients 75 Years and Older With ST-Segment–Elevation Myocardial Infarction<subtitle>One-Year Follow-up of a Large Prospective Cohort</subtitle>
2003
Early revascularisation and 1-year survival in 14-day survivors of acute myocardial infarction: a prospective cohort study
2002
Fibrinolytic therapy in patients 75 years and older with ST-segment-elevation myocardial infarction. One-year follow-up of a large prospective cohort
2003
Anticoagulation Therapy in Atrial Fibrillation in Combination With Acute Myocardial Infarction Influences Long-Term Outcome
2005
Under utilisation of evidence-based treatment partially explains for the unfavourable prognosis in diabetic patients with acute myocardial infarction.
2003
Early statin treatment following acute myocardial infarction and 1-year survival
2001
Influence of Renal Function on the Effects of Early Revascularization in Non-ST-Elevation Myocardial Infarction
2009